Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Visa
V
|
+$1.8B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.68B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$715M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$669M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$878M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$534M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$471M |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$344M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$325M |
Sector Composition
| 1 | Technology | 17.92% |
| 2 | Healthcare | 10.92% |
| 3 | Financials | 10.42% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Industrials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Strategic Education
STRA
$1.99B
| $3.23M | ﹤0.01% |
52,539
+2,397
| +5% | +$147K |
|
2927
First Trust Morningstar Dividend Leaders Index Fund
FDL
$5.78B
| $3.22M | ﹤0.01% |
100,226
+54,246
| +118% | +$1.74M |
|
|
FCAX
2928
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $3.22M | ﹤0.01% |
323,337
+312,942
| +3,011% | +$3.11M |
|
2929
AppFolio
APPF
$10B
| $3.22M | ﹤0.01% |
30,709
-42,235
| -58% | -$4.42M |
|
2930
Cassava Sciences
SAVA
$110M
| $3.21M | ﹤0.01% |
76,795
+39,238
| +104% | +$1.64M |
|
|
SHAC
2931
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $3.21M | ﹤0.01% |
325,140
-434,535
| -57% | -$4.29M |
|
|
NXDR
2932
Nextdoor Holdings
NXDR
$879M
| $3.2M | ﹤0.01% |
1,148,271
-1,073,655
| -48% | -$3M |
|
2933
Methode Electronics
MEI
$294M
| $3.2M | ﹤0.01% |
86,156
+3,248
| +4% | +$121K |
|
|
RACB
2934
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $3.2M | ﹤0.01% |
+325,366
| New | +$3.2M |
|
2935
Replimune Group
REPL
$265M
| $3.2M | ﹤0.01% |
184,976
-40,724
| -18% | -$703K |
|
2936
Anavex Life Sciences
AVXL
$745M
| $3.19M | ﹤0.01% |
309,313
-48,547
| -14% | -$501K |
|
2937
Telos
TLS
$497M
| $3.19M | ﹤0.01% |
358,326
-40,997
| -10% | -$364K |
|
2938
Addus HomeCare
ADUS
$2.02B
| $3.18M | ﹤0.01% |
33,382
+1,177
| +4% | +$112K |
|
2939
EchoStar
SATS
$20.5B
| $3.18M | ﹤0.01% |
192,777
+41,994
| +28% | +$692K |
|
2940
Ethan Allen Interiors
ETD
$758M
| $3.17M | ﹤0.01% |
149,718
-58,291
| -28% | -$1.23M |
|
2941
Bank of N.T. Butterfield & Son
NTB
$1.91B
| $3.17M | ﹤0.01% |
97,519
-11,674
| -11% | -$379K |
|
2942
Driven Brands
DRVN
$2.78B
| $3.16M | ﹤0.01% |
113,043
+51,969
| +85% | +$1.45M |
|
2943
Dimensional International High Profitability ETF
DIHP
$4.52B
| $3.16M | ﹤0.01% |
+165,717
| New | +$3.16M |
|
2944
Matthews International
MATW
$798M
| $3.16M | ﹤0.01% |
140,966
-107,860
| -43% | -$2.42M |
|
|
CSR
2945
Centerspace
CSR
$975M
| $3.15M | ﹤0.01% |
46,837
+16,902
| +56% | +$1.14M |
|
|
FINM
2946
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $3.15M | ﹤0.01% |
316,808
-167,862
| -35% | -$1.67M |
|
2947
Organogenesis Holdings
ORGO
$603M
| $3.13M | ﹤0.01% |
967,096
-81,215
| -8% | -$263K |
|
|
CHS
2948
DELISTED
Chicos FAS, Inc.
CHS
| $3.13M | ﹤0.01% |
647,032
-949,239
| -59% | -$4.59M |
|
2949
Sandstorm Gold
SAND
$3.44B
| $3.13M | ﹤0.01% |
605,209
-184,088
| -23% | -$952K |
|
2950
Esperion Therapeutics
ESPR
$554M
| $3.12M | ﹤0.01% |
465,799
+204,241
| +78% | +$1.37M |
|